<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Fluidigm Corporation

    Fluidigm Corporation

    Fluidigm (NASDAQ:FLDM) is an industry-leading biotechnology tools provider with a ...

    Fluidigm (NASDAQ:FLDM) is an industry-leading b...

    Filing Type:    PU
    Foamix Pharmaceuticals Ltd.

    Foamix Pharmaceuticals Ltd.

    Foamix Pharmaceuticals is a specialty pharmaceutical company, committed to address...

    Foamix Pharmaceuticals is a specialty pharmaceu...

    Filing Type:    PU
    Provention Bio, Inc.

    Provention Bio, Inc.

    Provention Bio, Inc. is a clinical-stage biopharmaceutical company developing nove...

    Provention Bio, Inc. is a clinical-stage biopha...

    Filing Type:    PU
    PLx Pharma Inc.

    PLx Pharma Inc.

    PLx Pharma Inc. (Nasdaq: PLXP), is a late-stage specialty pharmaceutical company i...

    PLx Pharma Inc. (Nasdaq: PLXP), is a late-stage...

    Filing Type:    PU
    Ocugen, Inc.

    Ocugen, Inc.

    Ocugen is a clinical stage biopharmaceutical company focused on discovering, devel...

    Ocugen is a clinical stage biopharmaceutical co...

    Filing Type:    PU
    NuCana plc

    NuCana plc

    We are a clinical-stage biopharmaceutical company focused on significantly improvi...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Onconova Therapeutics, Inc.

    Onconova Therapeutics, Inc.

    Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused o...

    Onconova Therapeutics, Inc. is a Phase 3-stage ...

    Filing Type:    PU
    ChemoCentryx, Inc.

    ChemoCentryx, Inc.

    ChemoCentryx is a biopharmaceutical company focused exclusively on discovering, de...

    ChemoCentryx is a biopharmaceutical company foc...

    Filing Type:    PU
    Cellular Biomedicine Group, Inc.

    Cellular Biomedicine Group, Inc.

    Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapie...

    Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.